Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.16ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.16ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.16NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CM.10ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CM.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CM.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.10NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.2.11ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.2.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.11NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.25ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.2.25ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.25ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.25NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.42ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.42ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.42ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.42NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.69ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.69ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.69ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
BQ.1.1.69NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.70ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-802.098France
BQ.1.1.70ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.70ENiu-ECACGTTAACAATATTGCAGC20402639126372R-4085China
BQ.1.1.70NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BN.1.5.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BN.1.5.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.5.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.5.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.31ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.31ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.31ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.31NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.41ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.41ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.41ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.41NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.46ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.46ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.46ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.46NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CP.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CP.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CP.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used